Bat and pig IFN-induced transmembrane protein 3 restrict cell entry by influenza virus and lyssaviruses

Journal of General Virology

Volumn 96, Issue 5, 2015, Pages 991-1005

  Benfield, Camilla T O ^a   Smith, Sarah E ^b   Wright, Edward ^c   Wash, Rachael S ^b   Ferrara, Francesca ^d   Temperton, Nigel J ^d   Kellam, Paul ^b,e  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

^d UNIVERSITY OF KENT   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HEMAGGLUTININ; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 3; MEMBRANE PROTEIN; NUCLEOPROTEIN; SMALL INTERFERING RNA; TRANSFERRIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; INTERFERON; RNA BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BAT; CELL MEMBRANE; CONTROLLED STUDY; DOMESTIC PIG; ENDOSOME; GENE AMPLIFICATION; HUMAN; INFLUENZA VIRUS; LYSSAVIRUS; MULTIVESICULAR BODY; MYOTIS MYOTIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; VIRUS REPLICATION; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; ORTHOMYXOVIRIDAE; PHYSIOLOGY; PIG; SEQUENCE HOMOLOGY; VIRUS ENTRY;

LYSSAVIRUS; MAMMALIA; MUS; MYOTIS MYOTIS; ORTHOMYXOVIRIDAE; SUIDAE; SUS SCROFA DOMESTICA;

ANIMALS; CHIROPTERA; CONSERVED SEQUENCE; INTERFERONS; LYSSAVIRUS; MEMBRANE PROTEINS; ORTHOMYXOVIRIDAE; RNA-BINDING PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SWINE; VIRUS INTERNALIZATION;

EID: 84926611956     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.000058     Document Type: Article

References (64)

1. Amengual, B., Bourhy, H., López-Roig, M. & Serra-Cobo, J. (2007). Temporal dynamics of European bat Lyssavirus type 1 and survival of Myotis myotis bats in natural colonies. PLoS ONE 2, e566.
2. Amini-Bavil-Olyaee, S., Choi, Y. J., Lee, J. H., Shi, M., Huang, I. C., Farzan, M. & Jung, J. U. (2013). The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 13, 452–464.
3. Anafu, A. A., Bowen, C. H., Chin, C. R., Brass, A. L. & Holm, G. H. (2013). Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. J Biol Chem 288, 17261–17271.
4. Andersson, M., Ahlberg, V., Jensen-Waern, M. & Fossum, C. (2011). Intestinal gene expression in pigs experimentally co-infected with PCV2 and PPV. Vet Immunol Immunopathol 142, 72–80.
5. Badrane, H. & Tordo, N. (2001). Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders. J Virol 75, 8096–8104.
6. Bailey, C. C., Huang, I. C., Kam, C. & Farzan, M. (2012). Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog 8, e1002909.
7. Bailey, C. C., Kondur, H. R., Huang, I. C. & Farzan, M. (2013). Interferon-induced transmembrane protein 3 is a type II transmembrane protein. J Biol Chem 288, 32184–32193.
8. Bean, A. G., Baker, M. L., Stewart, C. R., Cowled, C., Deffrasnes, C., Wang, L. F. & Lowenthal, J. W. (2013). Studying immunity to zoonotic diseases in the natural host – keeping it real. Nat Rev Immunol 13, 851–861.
9. Biesold, S. E., Ritz, D., Gloza-Rausch, F., Wollny, R., Drexler, J. F., Corman, V. M., Kalko, E. K., Oppong, S., Drosten, C. & Müller, M. A. (2011). Type I interferon reaction to viral infection in interferoncompetent, immortalized cell lines from the African fruit bat Eidolon helvum. PLoS ONE 6, e28131.
10. Bonifacino, J. S. & Traub, L. M. (2003). Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 72, 395–447.
11. Brass, A. L., Huang, I. C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L. & other authors (2009). The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243–1254.
12. Chen, Y. X., Welte, K., Gebhard, D. H. & Evans, R. L. (1984). Induction of T cell aggregation by antibody to a 16kd human leukocyte surface antigen. J Immunol 133, 2496–2501.
13. Demaison, C., Parsley, K., Brouns, G., Scherr, M., Battmer, K., Kinnon, C., Grez, M. & Thrasher, A. J. (2002). High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 13, 803–813.
14. Drexler, J. F., Corman, V. M., Wegner, T., Tateno, A. F., Zerbinati, R. M., Gloza-Rausch, F., Seebens, A., Müller, M. A. & Drosten, C. (2011). Amplification of emerging viruses in a bat colony. Emerg Infect Dis 17, 449–456.
15. Drexler, J. F., Corman, V. M., Müller, M. A., Maganga, G. D., Vallo, P., Binger, T., Gloza-Rausch, F., Cottontail, V. M., Rasche, A. & other authors (2012). Bats host major mammalian paramyxoviruses. Nat Commun 3, 796.
16. Drexler, J. F., Corman, V. M. & Drosten, C. (2014). Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antiviral Res 101, 45–56.
17. Duggal, N. K. & Emerman, M. (2012). Evolutionary conflicts between viruses and restriction factors shape immunity. Nat Rev Immunol 12, 687–695.
18. Everitt, A. R., Clare, S., Pertel, T., John, S. P., Wash, R. S., Smith, S. E., Chin, C. R., Feeley, E. M., Sims, J. S. & other authors (2012). IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519–523.
19. Everitt, A. R., Clare, S., McDonald, J. U., Kane, L., Harcourt, K., Ahras, M., Lall, A., Hale, C., Rodgers, A. & other authors (2013). Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model. PLoS ONE 8, e80723.
20. Fadel, H. J. & Poeschla, E. M. (2011). Retroviral restriction and dependency factors in primates and carnivores. Vet Immunol Immunopathol 143, 179–189.
21. Feeley, E. M., Sims, J. S., John, S. P., Chin, C. R., Pertel, T., Chen, L. M., Gaiha, G. D., Ryan, B. J., Donis, R. O. & other authors (2011). IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7, e1002337.
22. Ferrara, F., Molesti, E., Böttcher-Friebertshäuser, E., Cattoli, G., Corti, D., Scott, S. D. & Temperton, N. J. (2012). The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes. J Mol Genet Med 7, 309–314.
23. Ferrari, M., Scalvini, A., Losio, M. N., Corradi, A., Soncini, M., Bignotti, E., Milanesi, E., Ajmone-Marsan, P., Barlati, S. & other authors (2003). Establishment and characterization of two new pig cell lines for use in virological diagnostic laboratories. J Virol Methods 107, 205–212.
24. Friedman, R. L., Manly, S. P., McMahon, M., Kerr, I. M. & Stark, G. R. (1984). Transcriptional and posttranscriptional regulation of interferon- induced gene expression in human cells. Cell 38, 745–755.
25. Gouy, M., Guindon, S. & Gascuel, O. (2010). SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol 27, 221–224.
26. Hickford, D., Frankenberg, S., Shaw, G. & Renfree, M. B. (2012). Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genomics 13, 155.
27. Huang, I. C., Bailey, C. C., Weyer, J. L., Radoshitzky, S. R., Becker, M. M., Chiang, J. J., Brass, A. L., Ahmed, A. A., Chi, X. & other authors (2011). Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7, e1001258.
28. Jia, R., Pan, Q., Ding, S., Rong, L., Liu, S. L., Geng, Y., Qiao, W. & Liang, C. (2012). The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J Virol 86, 13697–13707.
29. John, S. P., Chin, C. R., Perreira, J. M., Feeley, E. M., Aker, A. M., Savidis, G., Smith, S. E., Elia, A. E., Everitt, A. R. & other authors (2013). The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J Virol 87, 7837–7852.
30. Kirmaier, A., Wu, F., Newman, R. M., Hall, L. R., Morgan, J. S., O’Connor, S., Marx, P. A., Meythaler, M., Goldstein, S. & other authors (2010). TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol 8, e1000462.
31. Kupferschmidt, K. (2013). Emerging infectious diseases. Link to MERS virus underscores bats’ puzzling threat. Science 341, 948–949.
32. Li, K., Markosyan, R. M., Zheng, Y. M., Golfetto, O., Bungart, B., Li, M., Ding, S., He, Y., Liang, C. & other authors (2013). IFITM proteins restrict viral membrane hemifusion. PLoS Pathog 9, e1003124.
33. Lu, J., Pan, Q., Rong, L., He, W., Liu, S. L. & Liang, C. (2011). The IFITM proteins inhibit HIV-1 infection. J Virol 85, 2126–2137.
34. Matrosovich, M., Matrosovich, T., Garten, W. & Klenk, H. D. (2006). New low-viscosity overlay medium for viral plaque assays. Virol J 3, 63.
35. McNatt, M. W., Zang, T., Hatziioannou, T., Bartlett, M., Fofana, I. B., Johnson, W. E., Neil, S. J. & Bieniasz, P. D. (2009). Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog 5, e1000300.
36. Miller, L. C., Jiang, Z., Sang, Y., Harhay, G. P. & Lager, K. M. (2014). Evolutionary characterization of pig interferon-inducible transmembrane gene family and member expression dynamics in tracheobronchial lymph nodes of pigs infected with swine respiratory disease viruses. Vet Immunol Immunopathol 159, 180–191.
37. Moffatt, P., Gaumond, M. H., Salois, P., Sellin, K., Bessette, M. C., Godin, E., de Oliveira, P. T., Atkins, G. J., Nanci, A. & Thomas, G. (2008). Bril: a novel bone-specific modulator of mineralization. J Bone Miner Res 23, 1497–1508.
38. Mudhasani, R., Tran, J. P., Retterer, C., Radoshitzky, S. R., Kota, K. P., Altamura, L. A., Smith, J. M., Packard, B. Z., Kuhn, J. H. & other authors (2013). IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol 87, 8451–8464.
39. Omatsu, T., Bak, E. J., Ishii, Y., Kyuwa, S., Tohya, Y., Akashi, H. & Yoshikawa, Y. (2008). Induction and sequencing of Rousette bat interferon a and b genes. Vet Immunol Immunopathol 124, 169–176.
40. Papenfuss, A. T., Baker, M. L., Feng, Z. P., Tachedjian, M., Crameri, G., Cowled, C., Ng, J., Janardhana, V., Field, H. E. & Wang, L. F. (2012). The immune gene repertoire of an important viral reservoir, the Australian black flying fox. BMC Genomics 13, 261.
41. Perreira, J. M., Chin, C. R., Feeley, E. M. & Brass, A. L. (2013). IFITMs restrict the replication of multiple pathogenic viruses. J Mol Biol 425, 4937–4955.
42. Provost, C., Jia, J. J., Music, N., Levesque, C., Lebel, M. E., del Castillo, J. R., Jacques, M. & Gagnon, C. A. (2012). Identification of a new cell line permissive to porcine reproductive and respiratory syndrome virus infection and replication which is phenotypically distinct from MARC-145 cell line. Virol J 9, 267.
43. Quan, P. L., Firth, C., Conte, J. M., Williams, S. H., Zambrana-Torrelio, C. M., Anthony, S. J., Ellison, J. A., Gilbert, A. T., Kuzmin, I. V. & other authors (2013). Bats are a major natural reservoir for hepaciviruses and pegiviruses. Proc Natl Acad Sci U S A 110, 8194–8199.
44. Seim, I., Fang, X., Xiong, Z., Lobanov, A. V., Huang, Z., Ma, S., Feng, Y., Turanov, A. A., Zhu, Y. & other authors (2013). Genome analysis reveals insights into physiology and longevity of the Brandt’s bat Myotis brandtii. Nat Commun 4, 2212.
45. Shan, Z., Han, Q., Nie, J., Cao, X., Chen, Z., Yin, S., Gao, Y., Lin, F., Zhou, X. & other authors (2013). Negative regulation of interferoninduced transmembrane protein 3 by SET7-mediated lysine monomethylation. J Biol Chem 288, 35093–35103.
46. Siegrist, F., Ebeling, M. & Certa, U. (2011). The small interferoninduced transmembrane genes and proteins. J Interferon Cytokine Res 31, 183–197.
47. Smith, I. & Wang, L. F. (2013). Bats and their virome: an important source of emerging viruses capable of infecting humans. Curr Opin Virol 3, 84–91.
48. Smith, S. E., Gibson, M. S., Wash, R. S., Ferrara, F., Wright, E., Temperton, N., Kellam, P. & Fife, M. (2013). Chicken interferoninducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro. J Virol 87, 12957–12966.
49. Smith, S., Weston, S., Kellam, P. & Marsh, M. (2014). IFITM proteins-cellular inhibitors of viral entry. Curr Opin Virol 4, 71–77.
50. Takahashi, S., Doss, C., Levy, S. & Levy, R. (1990). TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. J Immunol 145, 2207–2213.
51. Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S. & other authors (2013). New World bats harbor diverse influenza A viruses. PLoS Pathog 9, e1003657.
52. Wang, Z., Zhang, A., Wan, Y., Liu, X., Qiu, C., Xi, X., Ren, Y., Wang, J., Dong, Y. & other authors (2014). Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A 111, 769–774.
53. Warren, C. J., Griffin, L. M., Little, A. S., Huang, I. C., Farzan, M. & Pyeon, D. (2014). The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus. PLoS ONE 9, e96579.
54. Weidner, J. M., Jiang, D., Pan, X. B., Chang, J., Block, T. M. & Guo, J. T. (2010). Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 84, 12646–12657.
55. Wright, E., Temperton, N. J., Marston, D. A., McElhinney, L. M., Fooks, A. R. & Weiss, R. A. (2008). Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. J Gen Virol 89, 2204–2213.
56. Yount, J. S., Moltedo, B., Yang, Y. Y., Charron, G., Moran, T. M., López, C. B. & Hang, H. C. (2010). Palmitoylome profiling reveals Spalmitoylation- dependent antiviral activity of IFITM3. Nat Chem Biol 6, 610–614.
57. Yount, J. S., Karssemeijer, R. A. & Hang, H. C. (2012). SPalmitoylation and ubiquitination differentially regulate interferoninduced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J Biol Chem 287, 19631–19641.
58. Zhang, Z., Liu, J., Li, M., Yang, H. & Zhang, C. (2012). Evolutionary dynamics of the interferon-induced transmembrane gene family in vertebrates. PLoS ONE 7, e49265.
59. Zhang, G., Cowled, C., Shi, Z., Huang, Z., Bishop-Lilly, K. A., Fang, X., Wynne, J. W., Xiong, Z., Baker, M. L. & other authors (2013a). Comparative analysis of bat genomes provides insight into the evolution of flight and immunity. Science 339, 456–460.
60. Zhang, Y. H., Zhao, Y., Li, N., Peng, Y. C., Giannoulatou, E., Jin, R. H., Yan, H. P., Wu, H., Liu, J. H. & other authors (2013b). Interferoninduced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 4, 1418.
61. Zhao, X., Guo, F., Liu, F., Cuconati, A., Chang, J., Block, T. M. & Guo, J. T. (2014). Interferon induction of IFITM proteins promotes infection by human coronavirus OC43. Proc Natl Acad Sci U S A 111, 6756–6761.
62. Zhou, P., Cowled, C., Todd, S., Crameri, G., Virtue, E. R., Marsh, G. A., Klein, R., Shi, Z., Wang, L. F. & Baker, M. L. (2011). Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity. J Immunol 186, 3138–3147.
63. Zhou, P., Cowled, C., Wang, L. F. & Baker, M. L. (2013). Bat Mx1 and Oas1, but not Pkr are highly induced by bat interferon and viral infection. Dev Comp Immunol 40, 240–247.
64. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L. & Trono, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15, 871–875.